Pep2-AVKI
Based on 1 Customer Validation
Pep2-AVKI is a selective peptide inhibitor of the binding of the AMPA receptor subunit (GluR2) at the C-terminal PDZ site to C-kinase (PICK1). Pep2-AVKI does not affect the binding of (AMPA-type glutamate receptor) GluA2 to GRIP or ABP. Pep2-AVKI does not increase the amplitude of AMPA currents. pep2-AVKI can be used to study neurological diseases.
For research use only. We do not sell to patients.
- Purity: 99.24%
- CAS No.: 1315378-69-8
- Formula: C60H93N13O17
- Molecular Weight:1268.46
-
Storage:
Sealed storage, away from moisture.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
All iGluR Isoforms
More
Biological Activity
Pep2-AVKI (1 mM) selectively binds to PICK and does not alter (Miniature Excitatory Postsynaptic Current) mEPSC amplitude or frequency, but inhibits the activity-induced increase in (Excitatory Postsynaptic Current) EPSC amplitude ratio in cerebellar stellate cells[1].
Pep2-AVKI (1 mM) blocks the increase in synaptic GluR2-containing receptors in cerebellar stellate cells[1].
Pep2-AVKI increases AMPA-evoked (radiolabeled norepinephrine) [3H]NA and (radiolabeled D-aspartate) [3H]D-ASP and increases 10 μM NMDA/1 μM Glycine (HY-Y0966)/50 μM (S) AMPA-induced tritium release, but does not alter 10 μM NMDA/1 μM Glycine-induced [3H]D-ASP release in hippocampal synaptosomes[2][3].
Pep2-AVKI (100 μM) blocks (Long-Term Depression) LTD in postsynaptic neurons[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1315378-69-8
-
Appearance Solid
-
Molecular Weight 1268.46
-
Formula C60H93N13O17
-
Color White to off-white
-
Sequence
Tyr-Asn-Val-Tyr-Gly-Ile-Glu-Ala-Val-Lys-Ile
-
Sequence Shortening
YNVYGIEAVKI
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Sealed storage, away from moisture
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Purity & Documentation
-
Data Sheet (261 KB)
-
SDS (254 KB)
- English - EN (254 KB)
- Français - FR (254 KB)
- Deutsch - DE (254 KB)
- Norwegian - NO (254 KB)
- Español - ES (254 KB)
- Swedish - SV (254 KB)
- Italian - IT (254 KB)
- Korean - KR (254 KB)
- Portuguese - PT (254 KB)
-
Handling Instructions (2659 KB)
References
[1]. Liu SJ, et al. Subunit interaction with PICK and GRIP controls Ca2+ permeability of AMPARs at cerebellar synapses. Nat Neurosci. 2005 Jun;8(6):768-75. [Content Brief]
[2]. Pittaluga A, et al. Trafficking of presynaptic AMPA receptors mediating neurotransmitter release: neuronal selectivity and relationships with sensitivity to cyclothiazide. Neuropharmacology. 2006 Mar;50(3):286-96. [Content Brief]
[3]. Summa M, et al.Hippocampal AMPA autoreceptors positively coupled to NMDA autoreceptors traffic in a constitutive manner and undergo adaptative changes following enriched environment training. Neuropharmacology. 2011 Dec;61(8):1282-90. [Content Brief]
[4]. Toyoda H, et al. Long-term depression requires postsynaptic AMPA GluR2 receptor in adult mouse cingulate cortex. J Cell Physiol. 2007 May;211(2):336-43. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pep2-AVKI Related Classifications
HY-P1059 Related Classifications
Powered by Bioz